Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...

In a significant medical breakthrough, Russia has reportedly developed an mRNA vaccine against cancer, which will be made available to patients free of cost by 2025. The announcement was made by ...

Russia this week claimed it has developed its own mRNA-based vaccine to treat cancer, which will be available for free to patients from early 2025.(Pixabay) Russia this week claimed it has ...

Scientists at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have divulged compounds acting as Toll-like receptor 7 (TLR7) and TLR8 agonists reported to be useful for the treatment of cancer.

Vaccines may be contributing to an alarming rise in excess deaths. Doctors and healthcare professionals across the world have signed a petition calling for the immediate suspension of all COVID-19 ...

Several doctors and healthcare professionals have signed a petition calling for the immediate suspension of all COVID-19 mRNA products because they fear the jabs could be contributing to an alarming ...

研究成果以封面文章形式发表于最新一期《药学学报》（Acta Pharmaceutica Sinica B） 该研究开发了一种新喹啉衍生物TH-407b，作为人TLR7的特异性小分子抑制剂，该抑制剂在体内显示出疗效，提高了存活率并缓解了系统性红斑狼疮（SLE）模型小鼠的症状，为通过靶向TLR7 ...

Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But Moderna's mRNA-1403, now in Phase 3 trials, is based on the company's mRNA ...

National Key Laboratory of Green Pesticide, Hubei International Scientific and Technological Cooperation Base of Pesticide and Green Synthesis, International Joint Research Center for Intelligent ...

咪喹莫特（R837）是一种免疫佐剂，通过激活先天免疫系统中的TLR7受体，增强免疫细胞对肿瘤或病毒感染的免疫反应，常用于肿瘤免疫治疗和抗病毒治疗。介孔聚多巴胺（MPDA）纳米粒是一种具有良好生物相容性和高表面积的智能纳米材料，能够负载和控释药物 ...